FacebookTwitterGoogle+RedditEmail

The Return of FrankenSalmon

by MARTHA ROSENBERG

The genetically engineered AquAdvantage salmon, (AAS), often referred to as a “Frankenfish”, is moving through the FDA approval process despite doubts raised at 2010 hearings, in scientific reports and by 400,000 consumers.

The genetically modified salmon, created by Boston-based AquaBounty Technologies, is created to grow twice as fast as wild Atlantic salmon–reaching its full size in 18 months instead of three years. It was created by inserting the coding sequence from a Chinook salmon growth hormone gene under the control of an “antifreeze protein promoter and terminator” from ocean pout into wild Atlantic salmon. No wonder it’s called a Frankenfish.

Ninety-five to 99 percent of AAS are sterile, said AquaBounty at FDA hearings in 2010, so they are unlikely to breed and threaten wild salmon stocks if they escape. (If they did breed, though, it could Jurassic Park-like since AAS eat five times more food than wild salmon and have less fear of predators, according to background materials.) Nor is 1 to 5 percent a small amount considering the 15 million eggs AquaBounty plans to grow: that could amount to 750,000 fertile fish.

To prevent such risks, AquaBounty told an FDA advisory committee it plans to grow the eggs at a facility on Prince Edward Island in Canada, where escapees could not survive. “Water from the facility, including effluent from all floor drains, fish tanks and egg incubators, eventually discharges” into a tidal river that flows into the Gulf of Lawrence, says the AquAdvantage FDA briefing package. Because water temperatures in the winter months are very low and the water has a high salinity, “it is highly unlikely that early life stages of any Atlantic salmon at the facility would be able to survive if they were able to escape.”

But escape into the Gulf of Lawrence is not the only risk. AquaBounty also has safety plans for the adult salmon, which it plans to grow out and slaughter in the country of Panama because that environment  is also hostile to survival. “In the lower reaches of the watershed, the water temperature is in the range of 26 to 28 degrees C, at or near the upper incipient lethal level for Atlantic salmon,” says the FDA report. “As a result, it is extremely unlikely that AquAdvantage Salmon would ever be able to survive and migrate to the Pacific Ocean.”

In the FDA briefing report, AquAdvantage salmon were also found to have high incidences of “jaw erosion” and “focal inflammation” (infection), though the defects are said to be “of low magnitude and not likely to be debilitating to fish in a production setting.” What about the people who eat them? The report also identified low glucose
levels and a possible “increase in the level of IGF-1 [insulin-like growth factor-1] in the AquAdvantage salmon compared to sponsor control fish.”

Perhaps most troubling at the FDA hearings was AquaBounty’s policy for handling dead fish in Panama. In its Environmental Assessment report, it says, “As dead fish are deposited, they will be covered with caustic lime, followed by another layer of dead fish and caustic lime, and so on, until the burial pit is ~0.5 m deep, at which point it will [be] sealed with plastic and covered with soil. Successive pits will be located at a minimum distance of 0.5–1.0 m from those used previously; the aggregate collection of such pits will be located on high ground that is not within the 100-year flood plain. . . . In the event that disposal capacity at the site is inadequate to handle the immediate or aggregate waste volume, alternative means of disposal will be sought.” Why are so many fish expected to die?

More Concerns

There are also questions about the GE fish’s allergic potential. When FDA food scientists Kathleen Jones and Kevin Greenlees presented AquaBounty’s AquAdvantage salmon allergy studies at 2010 hearings, members on the committee considering the approval were appalled at the “science.”

How can safety be determined for levels of allergens when a number that would “unsafe” has not been determined asked members of the Veterinary Medicine Advisory Committee. It’s as if  “you selected a particular allergen in goat meat and another allergen that was in sheep meat and you compared the two and you found a significant difference but both of them were at irrelevantly low numbers,” said Louisiana State University’s David F. Senior, who chaired the committee. “Who cares?”  Other members berated the low numbers of fish used in studies, the inclusion of irrelevant fish in studies which “diluted out the power of the study,” and the generally bad science.

And not only were the studies low powered, some having only six or seven fish in them, there were errors in studies! James D. McKean, with the Department of Veterinary Diagnostic and Production Animal Medicine at Iowa State University, noted there were six “controls” in Table 15 and “in Table 16, there are 7. And I am still unclear as to where that extra sample came from?”

“Nothing reliable can be gained from this study,” said Craig Altier, DVM, from the College of Veterinary Medicine at Cornell University about other data presented, calling the work a “real mess.” This “is an important thing to study and the experiment was a bust, why hasn’t it been done again?”

The briefing packet even says the FDA an not determine if the AquAdvantage salmon would cause more allergies than other fish because excessive culling of “abnormal” salmon and other “technical flaws” in AquaBounty’s study so “skewed” data as to “limit its interpretation that we cannot rely on its results”!  What? Why are so many fish expected to be flawed–and why is approval even considered?

The briefing report also identified low glucose levels in the fish and a possible “increase in the level of IGF-1 [insulin-like growth factor-1] in the AquAdvantage salmon compared to sponsor control fish.”  IGF-1 is linked to cancer and early puberty and its presence in rBGH-created milk was what made the product so controversial. Government scientists have said that IGF-1 is destroyed by digestion or pasteurization, but other scientists disagree.

And there are other concerns besides the AquAdvantage salmon’s allergic potential and levels of its IGF-1. While supporters claim the fast growing fish would supply desirable omega oils,  according to Michael Hansen, PhD, senior scientist with Consumers Union, “in terms of the ratio of omega-3 to omega-6 fatty acids, GE salmon fare worse than wild fish and slightly worse than farmed salmon.”

Finally, there are Jurassic Park-like questions that persist with all genetically modified organisms. The FDA briefing packet discloses an unexpected and unwanted coding “rearrangement” in AquAdvantage salmon in which the original inserted genetic material has moved from “the far upstream promoter regions” to a “downstream location relative to the growth hormone coding region.”  Why.

Despite its documented aberrations, the AquAdvantage salmon will likely not even be  labeled in more evidence that the FDA puts industry before consumers.

Martha Rosenberg’s is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

June 22, 2017
Jason Hirthler
Invisible Empire Beneath the Radar, Above Suspicion
Ken Levy
Sorry, But It’s Entirely the Right’s Fault
John Laforge
Fukushima’s Radiation Will Poison Food “for Decades,” Study Finds
Ann Garrison
Jeremy Corbyn, the Labour Party, and the UK’s Socialist Surge
Phillip Doe
Big Oil in the Rocky Mountain State: the Overwhelming Tawdriness of Government in Colorado
Howard Lisnoff
The Spiritual Death of Ongoing War
Stephen Cooper
Civilized, Constitution-Loving Californians Will Continue Capital Punishment Fight
Bruno Rodríguez Parrilla
Cuba Will Not Bow to Trump’s Threats
Ramzy Baroud
Israel vs. the United Nations: The Nikki Haley Doctrine
Tyler Wilch
The Political Theology of US Drone Warfare
Colin Todhunter
A Grain of Truth: RCEP and the Corporate Hijack of Indian Agriculture
Robert Koehler
When the Detainee is American…
Jeff Berg
Our No Trump Contract
Faiza Shaheen
London Fire Fuels Movement to Challenge Inequality in UK
Rob Seimetz
Sorry I Am Not Sorry: A Letter From Millennials to Baby Boomers
June 21, 2017
Jim Kavanagh
Resist This: the United States is at War With Syria
James Ridgeway
Good Agent, Bad Agent: Robert Mueller and 9-11
Diana Johnstone
The Single Party French State … as the Majority of Voters Abstain
Ted Rall
Democrats Want to Lose the 2020 Election
Kathy Kelly
“Would You Like a Drink of Water?” Please Ask a Yemeni Child
Russell Mokhiber
Sen. Joe Manchin Says “No” to Single-Payer, While Lindsay Graham Floats Single-Payer for Sick People
Ralph Nader
Closing Democracy’s Doors Until the People Open Them
Binoy Kampmark
Barclays in Hot Water: The Qatar Connection
Jesse Jackson
Trump Ratchets Up the Use of Guns, Bombs, Troops, and Insults
N.D. Jayaprakash
No More Con Games: Abolish Nuclear Weapons Now! (Part Four)
David Busch
The Kingdom of Pence–and His League of Flaming Demons–is Upon Us
Stephen Cooper
How John Steinbeck’s “In Dubious Battle” Helps Us Navigate Social Discord
Madis Senner
The Roots of America’s Identity and Our Political Divide are Buried Deep in the Land
June 20, 2017
Ajamu Baraka
The Body Count Rises in the U.S. War Against Black People
Gary Leupp
Russia’s Calm, But Firm, Response to the US Shooting Down a Syrian Fighter Jet
Maxim Nikolenko
Beating Oliver Stone: the Media’s Spin on the Putin Interviews
Michael J. Sainato
Philando Castile and the Self Righteous Cloak of White Privilege
John W. Whitehead
The Militarized Police State Opens Fire
Peter Crowley
The Groundhog Days of Terrorism
Norman Solomon
Behind the Media Surge Against Bernie Sanders
Pauline Murphy
Friedrich Engels: a Tourist In Ireland
David Swanson
The Unifying Force of War Abolition
Louisa Willcox
Senators Bernie Sanders, Cory Booker, Tom Udall Back Tribes in Grizzly Fight
John Stanton
Mass Incarceration, Prison Labor in the United States
Robert Fisk
Did Trump Denounce Qatar Over Failed Business Deals?
Medea Benjamin
America Will Regret Helping Saudi Arabia Bomb Yemen
Brian Addison
Los Angeles County Data Shows Startling Surge in Youth, Latino Homelessness
Native News Online
Betraying Indian Country: How Grizzly Delisting Exposes Trump and Zinke’s Assault on Tribal Sovereignty and Treaty Rights
Stephen Martin
A Tragic Inferno in London Reflects the Terrorism of the Global Free Market
Debadityo Sinha
Think Like a River
FacebookTwitterGoogle+RedditEmail